2002 Surveillance Slides

This is an archived document. The links and content are no longer being updated.

Return to 2002 Surveillance Slides Main Menu

Primary Anti-TB Drug Resistance

United States, 1993-2002

Slide 18: Primary Anti-TB Drug Resistance, United States, 1993-2002. Primary drug resistance is estimated for the previous 10 years. The graph starts in 1993 because this is the year in which the individual TB case reports submitted to the national surveillance system began collecting information on initial susceptibility test results (for isolates) from patients with culture-positive TB. Data were available for more than 85% of culture-positive cases for each year. Primary resistance was estimated by using data from persons with no reported prior TB episode. Resistance to at least isoniazid remained between 7 and 8%. However, resistance to at least isoniazid and rifampin known as multidrug-resistant TB (MDR TB) decreased from 2.5% in 1993 to 1.0% each year during 1998-2001, with an increase to 1.2% in 2002.

Back to 2002 Surveillance Slides Main Page

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov